The PACMAN-AMI trial: game over for the "vulnerable plaque"?
Rocco Vergallo1, Carlo Patrono2
1Department of Cardiovascular Medicine, Interventional Cardiology Unit, Fondazione Policlinico Universitario A. Gemelli-IRCCS, Catholic University of the Sacred Heart, Largo A. Gemelli, 8, 00168 Rome, Italy.
European Heart Journal
|April 25, 2022
Summary
No abstract available in PubMed .


